| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |